Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FZ4TH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,579
Award facts
- Contract value 100% obligated
- $34,579.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $34,579.43 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Cosentyx (secukinumab) 300 mg pen auto-injectors in 2 ml formulations. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 30, 2025, and performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical supply vehicle through December 2026 that supports military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Pennsylvania that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company has demonstrated substantial capability in fulfilling competitive federal pharmaceutical contracts through its extensive portfolio of medical product deliveries with the Defense Logistics Agency's Medical Supply Chain. This award represents the company's continued role in supplying specialized pharmaceutical products, including immunologic and biologic agents, to support Department of Defense healthcare requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FZ4TH?
SPE2DR26FZ4TH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FZ4TH worth?
The government has obligated $34,579 on SPE2DR26FZ4TH.
Is contract SPE2DR26FZ4TH an order under another contract?
Yes. SPE2DR26FZ4TH is a delivery order under SPE2DR25D1050, an indefinite delivery contract.
Was contract SPE2DR26FZ4TH competed?
The extent of competition for SPE2DR26FZ4TH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award